ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Synovitis"

  • Abstract Number: 2331 • ACR Convergence 2024

    Assessment of the Likelihood of Joint Inflammation Recurrence in Previously Affected Joints During Psoriatic Arthritis Disease Course

    Dafne Capelusnik1, Ori Elkayam2 and Mark Berman3, 1Tel Aviv Sourasky Medical Center, Ramat Gan, Israel, 2Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 3Tel Aviv Sourasky Medical Center, Kefar sava, Israel

    Background/Purpose: Psoriatic arthritis (PsA) is a chronic inflammatory disease that can cause joint pain, swelling, and stiffness. Patients often experience flares followed by periods of remission.…
  • Abstract Number: 2637 • ACR Convergence 2024

    Chaperone-mediated Autophagy in Synovitis Distinguishes Psoriatic Arthritis from Rheumatoid Arthritis

    Vincenzo Venerito1, Gerardo Cazzato2, Fabio Cacciapaglia3, Eleonora Ceglie4, Sergio Del Vescovo4, Teresa Caferri4, Giuseppe Lopalco4, Francesco Girolamo5 and Florenzo Iannone1, 1Rheumatology Unit- University of Bari "Aldo Moro", IT, Bari, Italy, 2Pathology Unit - University of Bari "Aldo Moro", IT, Bari, Italy, 3Rheumatology Unit � DiMePRe-J, University and AOU Policlinico of Bari, Italy, Bari, Italy, 4Rheumatology Unit - University of Bari "Aldo Moro", IT, Bari, Italy, 5Human Anatomy Department - University of Bari "Aldo Moro", IT, Bari, Italy

    Background/Purpose: Recent studies have suggested that autophagy may play different roles in the pathogenesis of rheumatoid arthritis (RA) and psoriatic arthritis (PsA). Lysosome-associated membrane protein type 2A…
  • Abstract Number: 0021 • ACR Convergence 2024

    A Novel Small Molecule Screening Assay Using Normal Human Chondrocytes Toward Osteoarthritis Drug Discovery

    Philip Coryell1, Kenneth Pearce2, Paul Hardy2, Susan Chubinskaya3 and Richard Loeser4, 1University of North Carolina-Chapel Hill, Chapel, NC, 2University of North Carolina-Chapel Hill, Chapel Hill, NC, 3University of Texas Medical Branch, Galveston, TX, 4University of North Carolina, Chapel Hill, NC

    Background/Purpose: A central feature of osteoarthritis (OA) is progressive cartilage degradation driven by increased production of matrix degrading enzymes including MMP-13. There is a critical…
  • Abstract Number: 0031 • ACR Convergence 2024

    Beyond Pain and Inflammation: Intra-articular Liraglutide’s Comprehensive Benefits on Synovial Health and Cartilage in Osteoarthritis Compared to Dexamethasone

    Coralie Meurot1, Celine Martin1, Margot Vieubled1, Jerome Breton1, Indira Toillon2, Revital Rattenbach3 and Francis Berenbaum2, 14Moving Biotech, lille, France, 2Sorbonne University, Paris, France, 34Moving Biotech, Paris, France

    Background/Purpose: Osteoarthritis (OA) is an age-related joint disease that causes chronic pain and limited mobility. Patients mainly have access to therapies aimed at reducing inflammation…
  • Abstract Number: 0220 • ACR Convergence 2024

    Ultrasound-assessed Dactylitis as a Biomarker in the Early Diagnosis of Psoriatic Arthritis

    Otto Olivas-Vergara1, Raquel Largo2, Lina Martínez-Estupiñán3, Fredeswinda Romero-Bueno4, Olga Sánchez-Pernaute3, Javier R. Godo3, Maria del Carmen Fariña-Sabaris5, Belen Ruffin Vicente5, Carmen Herencia6, Aránzazu Mediero2, Agustina Criado Alcazar7, Pablo E. Borges1, Sheila Recuero-Díaz1, Andrea Alvear-Torres3, Amalia Gil3, Antía García-Fernández3, Ana Elena Hoyo Fernandez8, M. Isabel Sanchez-Barba8, M. Belen Ortega Trompeta8, Cristina Vazquez-Carballo9, Gabriel Herrero-Beaumont3 and ESPERANZA NAREDO10, 1Department of Rheumatology and Joint and Bone Research Unit. Hospital Universitario Fundación Jiménez Díaz and IIS-FJD, Madrid, Spain, 2Joint and Bone Research Unit. IIS-Fundación Jiménez Díaz, Madrid, Spain, 3Department of Rheumatology and Joint and Bone Research Unit. Hospital Universitario Fundación Jiménez Díaz and IIS-FJD. Autonomous University of Madrid, Madrid, Spain, 4Hospital Universitario Fundación Jiménez Díaz and IIS-FJD. Autonomous University of Madrid, Madrid, Spain, 5Department of Dermatology.Hospital Universitario Fundación Jiménez Díaz and IIS-FJD. Autonomous University of Madrid, Madrid, Spain, 6Joint and Bone Research Unit. IIS-Fundación Jiménez Díaz, M, Spain, 7Primary Care..Centro de Salud Paseo Imperial, Madrid, Spain, 8Primary Care.Centro de Salud Paseo Imperial, Madrid, Spain, 9Joint and Bone Research Unit. IIS-Fundación Jiménez Díaz. Autonomous University of Madrid, Madrid, Spain, 10Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

    Background/Purpose: The primary objective of this prospective, longitudinal, observational study was to evaluate the predictive value of ultrasound (US)-detected elementary lesions of dactylitis together with…
  • Abstract Number: L05 • ACR Convergence 2023

    DICKENS: A Multicentre Randomised Controlled Trial of Diacerein for Knee Osteoarthritis with Effusion-Synovitis

    Guoqi Cai1, Graeme Jones2, Flavia Cicuttini3, Anita Wluka3, Yuanyuan Wang3, Catherine Hill4, Helen Keen5, Benny Antony2, barbara de Graaff2, Michael Thompson2, Tania Winzenberg2, Kathy Buttigieg2, Petr Otahal2 and Dawn Aitken2, 1School of Public Health, Anhui Medical University, Hefei, China, 2Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia, 3Monash University, Melbourne, Australia, 4The Queen Elizabeth Hospital, University of Adelaide, Adelaide, Australia, 5Fiona Stanley Hospital, Murdoch, Australia

    Background/Purpose: There is an unmet need for treatments of knee OA. Diacerein is recommended for alleviating pain in OA patients for its anti-inflammatory effect by…
  • Abstract Number: 0385 • ACR Convergence 2023

    Heterogeneity of the Joint Location Supports the Importance of Local Factors in Early RA Synovitis : Analysis of the ERA UCLouvain Brussels Cohort

    Laura BRICMAN1, clement triaille2, Francesco Natalucci3, Emilie Sapart2, Tatiana Sokolova4, Aleksandra AVRAMOVSKA1, Thomas KIRCHGESNER5 and Patrick Durez2, 1Rheumatology, Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium, 2Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Rheumatology, Brussels, Belgium, 3UCLouvain University, Sermoneta, Italy, 4Université Catholique de Louvain, Brussels, Belgium, 5Rheumatology, Cliniques Universitaires Saint-Luc Département d'imagerie médicale – Université catholique de Louvain (UCLouvain), Brussels, Belgium

    Background/Purpose: ERA is considered to be a systemic disorder, but the role of local factors in driving synovial inflammation is increasingly being recognized. These joint-specific…
  • Abstract Number: 1721 • ACR Convergence 2023

    The Therapeutic Effects of Gingival Mesenchymal Stem Cells and Their Exosomes in a Chimeric Model of Rheumatoid Arthritis

    shane Bruckner1, Braden Zeno2, Vittoria Capria1, William Willis3, Latha Prabha Ganesan1 and wael Jarjour1, 1Ohio State University, Columbus, OH, 2Ohio State University, Upper Arlington, OH, 3Ohio State University, Reynoldsburg, OH

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that leads to progressive joint destruction involving multiple joints. There is a large body of…
  • Abstract Number: 0399 • ACR Convergence 2023

    Differential Synovial Tissue Enrichment of Oxylipins and Their Mediators Across Rheumatoid Arthritis Trajectory

    Simone Perniola1, Jessica Murillo-Saich2, Barbara Tolusso3, Clara Di Mario3, Marco Gessi4, Dario Bruno5, Luca Petricca6, Maria Rita Gigante6, Elisa Gremese5, Monica Guma7 and Stefano Alivernini8, 1Division of Clinical Immunology – Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 2Department of Medicine, University of California San Diego, La Jolla, CA, 3Immunology Research Core Facility – Gemelli Science and Technology Park (GSTeP) - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 4Division of Pathology - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 5Division of Rheumatology, Institute of Rheumatology and Affine Sciences, School of Medicine, Catholic University of the Sacred Heart, Roma, Italy, 6Division of Rheumatology - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 7University of California San Diego, La Jolla, CA, 8Immunology Research Core Facility, Gemelli Science and Technology Park, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Division of Rheumatology - Fondazione Policlinico Universitario A. Gemelli IRCCS - Università Cattolica del Sacro Cuore, Rome, Italy

    Background/Purpose: Synovial membrane represents the target tissue of Rheumatoid Arthritis (RA) inflammation. Our study aimed to perform a comprehensive quantification of oxylipins and their precursors…
  • Abstract Number: 1727 • ACR Convergence 2023

    Arthritogenicity of Homocitrullinated Peptides in HLA-DRB1 Transgenic Mice

    Sheri Saunders, Garth Blackler, Patti Kiser, Ewa Cairns and Lillian Barra, Western University, London, ON, Canada

    Background/Purpose: Most rheumatoid arthritis (RA) patients express autoantibodies to post-translationally modified antigens, including citrullinated and homocitrullinated (also known as carbamylated) peptides. Homocitrulline and citrulline are…
  • Abstract Number: 0401 • ACR Convergence 2023

    Resolution of Swollen Joint Count Is an Important Clinical Objective in Early Rheumatoid Arthritis : Analysis of the UCLouvain Brussels ERA Cohort and Comparison with the Remission Composite Index

    Francesco Natalucci1, clement triaille2, Emilie Sapart2, Laura BRICMAN3, Cécile VAN MULLEM2, Charlotte Desmet2, Stéphanie DIERCKX4, Marie DOYEN2, Tatiana Sokolova5, Aleksandra AVRAMOVSKA3 and Patrick Durez2, 1UCLouvain University, Sermoneta, Italy, 2Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Rheumatology, Brussels, Belgium, 3Rheumatology, Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium, 4CHU UCL Namur, Rheumatology, Mont-Godinne, Belgium, Mont Godinne, Belgium, 5Université Catholique de Louvain, Brussels, Belgium

    Background/Purpose: Rheumatoid Arthritis is a chronic autoimmune disease characterized by persistent joint inflammation. According to international guidelines, the treatment target should aim to reach the…
  • Abstract Number: 1744 • ACR Convergence 2023

    Histological and Molecular Comparison in the Synovial Tissue of Patients with Active Rheumatoid Arthritis to Remission

    Selina Ohl1, Klaus Frommer1, Markus Rickert2, Stefan Rehart3, Ulf Müller-Ladner1 and Elena Neumann1, 1Justus Liebig University Gießen, Campus Kerckhoff, Bad Nauheim, Germany, 2Dept. of Orthopaedics and Orthopaedic Surgery, University Hospital Giessen and Marburg, Giessen, Germany, 3Dept. of Orthopaedics and Trauma Surgery, Agaplesion Markus Hospital Frankfurt, Frankfurt, Germany

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease which leads to local and systemic manifestations. Subsequently, the inflamed synovium drives the destruction of…
  • Abstract Number: 0408 • ACR Convergence 2023

    The Role of Synovial Biopsy in Evaluating Rheumatoid Arthritis Acitivity in Patients: Findings from a Study of 30 Patients Treated with Adalimumab

    Rui Wu and YIlin Peng, the first affilated hospital of Nanchang University, Nanchang, China

    Background/Purpose: Rheumatoid arthritis(RA)is a chronic autoimmune disease that is characterized by inflammation and destrction of synovial jionts  which result in high disabilty. Treat-to-Target is critical…
  • Abstract Number: 1750 • ACR Convergence 2023

    Dysregulated NUB1 and Neddylation Enhances Rheumatoid Arthritis Fibroblast-Like Synoviocyte Inflammatory Responses

    Sho Sendo1, Camilla R. L. Machado2, Robert Benschop3, Narayanan B. Perumal4, Eunice Choi5, David Boyle5, Wei Wang5 and Gary Firestein2, 1Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan, 2University of California San Diego, San Diego, CA, 3Eli Lilly and Company, Indianapolis, IN, 4Eli Lilly and Company, San Diego, CA, 5University of California San Diego, La Jolla, CA

    Background/Purpose: Fibroblast-like synoviocytes (FLS) contribute to the pathogenesis of rheumatoid arthritis (RA), especially cartilage damage and cytokine production. These cells display an aggressive phenotype in…
  • Abstract Number: 0418 • ACR Convergence 2023

    Synovial Fluid Cell Counts Associated with Joint Histopathology in Rheumatoid Arthritis

    Edoardo Spolaore1, Edward DiCarlo2, Daniel Ramirez2, Melanie Smith2, Amit Lakhanpal2, Bella Mehta3, Laura Donlin2, Susan Goodman2 and Dana Orange4, 1HSS, New York, NY, 2Hospital for Special Surgery, New York, NY, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 4The Rockefeller University, New York, NY

    Background/Purpose: While analysis of synovial fluid white blood cell counts (WBCs) is performed in clinical practice for diagnosing septic arthritis and differentiating noninflammatory from inflammatory…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 11
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology